SlideShare ist ein Scribd-Unternehmen logo
1 von 45
Management of goiters, simple and
toxic
outline
Management of goiters,sep.2010
2
ď‚— Thyroid anatomy
ď‚— Thyroid physiology
ď‚— Evaluation of patients with thyroid diseases
ď‚— Management of simple goiters
ď‚— Management of toxic goiters
ď‚— References
Thyroid anatomy
Management of goiters,sep.2010
3
ď‚— two lobes connected by an isthmus
ď‚— 20 grams
ď‚— posterior to strap muscles in the anterior neck
ď‚— lobules that contain 20 to 40 follicles each
ď‚— 3 million follicles exist in the adult male
Anatomy
Management of goiters,sep.2010
4
Thyroid physiology
Management of goiters,sep.2010
5
ď‚— Thyroid hormone synthesis
ď‚— Iodide trapping
ď‚— Oxidation of iodide & iodination of tyrosine by
thyroid peroxidase
ď‚— Coupling of MIT and DIT to form T4 and T3
ď‚— Hydrolysis of thyroglobulin to release free T3 and T4
Thyroid hormone synthesis
Management of goiters,sep.2010
6
Thyroid physiology cont…
Management of goiters,sep.2010
7
ď‚— All of T4 is produced in the thyroid while only 20%
of T3.
ď‚— T3&T4 are transported bound TBG,TBPA and TBA
 Hypothalamo – pituitary – thyroid axis controls
secretion
Hypothalamo – pituitary – thyroid
axis
Management of goiters,sep.2010
8
Effects of thyroid hormones
Management of goiters,sep.2010
9
ď‚— Affects almost every system in the body
ď‚— Fetal brain &skeletal development
ď‚— Increase O2 consumption,BMR& heat production
ď‚— Positive inotropic and chronotropic on heart
ď‚— Increased GI motility,etc.
Evaluation of patients with thyroid
disease
Management of goiters,sep.2010
10
ď‚— TFT
 Serum TSH – most sensitive test for
diagnosis of hypo and hyperthyroidism
ď‚— Free T3&T4- for diagnosis of early
hyperthyroidism
ď‚— Total T3&T4-are not good for screening,
can be affected by factors other than
thyroid function
ď‚—Calcitonin
Evaluation cont…
Management of goiters,sep.2010
11
ď‚— TRH test-to asses pituitary TSH
secretion
ď‚— Thyroid antibodies(anti Tg,anti TPO and
TSI)
ď‚— elevated in autoimmune thyroid
d.(Graves d/Hashimoto’s thyroiditis)
Don’t indicate thyroid function
ď‚— Serum thyroglobulin
ď‚— for monitoring recurrent/metastatic
thyroid ca.
Evaluation cont…
Management of goiters,sep.2010
12
ď‚— Thyroid imaging
ď‚— Radionuclide imaging
ď‚— Size, shape & function of gland assessed
 Increased uptake=“hot", less risk of
malignancy,<5%
 Decreased uptake=“cold" higher risk of
malignancy (15-20%)
ď‚— Ultrasound
ď‚— CT/ MRI good for assessment of
retrosternal extension
RAI Scanning
Management of goiters,sep.2010
13
Evaluation cont…
Management of goiters,sep.2010
14
ď‚— FNAC
ď‚—The best investigative modality for
detecting malignancy
ď‚—When guided by ultrasound has high
sensitivity and specificity
ď‚—Reduced thyroidectomies by 50%
ď‚— Biopsy
Simple goiters
Management of goiters,sep.2010
15
Simple goiters cont…
Management of goiters,sep.2010
16
ď‚— Race = no racial predilection
ď‚— Sex= female to male ratio 4:1
ď‚— Spectrum of illness
ď‚—Diffuse
ď‚—Uninodular(Solitary Nodule)
ď‚—Multinodular
ď‚—Cystic enlargement
Diagnosis
Management of goiters,sep.2010
17
ď‚— Most are asymptomatic
ď‚— If symptomatic
ď‚—Neck mass
ď‚—Compression symptoms mainly in
intrathoracic extension
ď‚—Hoarseness of voice
ď‚— FNAC is important to exclude
malignancy
Treatment of simple goiters
Management of goiters,sep.2010
18
I. Multinodular goiters
ď‚— no ideal treatment
ď‚—Options are
A. Iodine supplementation-not
effective on nodular goiter,
abandoned
B.L thyroxine suppression therapy
15 – 40 % reduction in size in 3
months
ď‚— More effective on small diffuse
goiters
Treatment cont…
Management of goiters,sep.2010
19
C . Surgery
ď‚—The preferred modality
ď‚—Indicated for:
-large goiters with compression
symptoms, -in suspicion of
malignancy &
-cosmosis
ď‚—Advantages
ď‚— Significant goiter reduction with prompt relief of
symptoms
ď‚— Definitive tissue diagnosis
Treatment cont…
Management of goiters,sep.2010
20
ď‚—Disadvantages
ď‚— Many complications
 Recurrence in 15 – 40%
ď‚— Long term risk of
hypothyroidism(10-20%)
D.Radioiodine therapy(I131)
ď‚—Not effective in larger goiters, with
higher recurrence
ď‚—40- 60% reduction in size in 1 to 2
years
ď‚—Small Goiters:-Recurrence is low(8%
Management of goiters,sep.2010
21
II.Solitary nodule
A.Small sized(1-1.5 cm) no treatment,
followed regularly with FNAC(3-6% risk of
malignancy)
B.Solitary cold nodule
 T4 therapy – helps to shrink the nodule
ď‚— Surgery( lobectomy or isthmusectomy)
ď‚— In malignant or suspicious cytology
ď‚— Cosmetic
ď‚— Pressure symptoms
ď‚— Percutaneous ethanol injection therapy
Treatment cont…
Treatment cont…
Management of goiters,sep.2010
22
III. Solitary cyst –accounts for 15-25% of
thyroid nodules
ď‚— FNAC needed always to exclude
malignancy
ď‚— If small (<2-3cm) and benign should be left
untreated
 If large(>2-3cm) – aspiration is effective
 Surgery –in suspicious or non diagnostic
cytology & recurrence after aspiration
 PEIT – good success(61-95% reduction in
size)
Toxic goiters
Management of goiters,sep.2010
23
ď‚— Include
Toxic diffuse goiter (Grave’s disease)
ď‚—Toxic multinodular goiter (TMNG)
Toxic solitary nodule(Plummer’s
disease)
ď‚—Thyroiditis
Toxic goiters cont…
Management of goiters,sep.2010
24
I . Grave’s disease
ď‚—Most common cause of
hyperthyroidism
ď‚—Prevalence of 3per 1000 in the USA
ď‚—an autoimmune disease of unknown
etiology
ď‚—M:F ratio 1:5 and peak age of 20 - 40
years
ď‚—Mediated by thyroid stimulating
antibodies
ď‚—The gland is diffusely & smoothly
Toxic goiters (Grave’s) cont…
Management of goiters,sep.2010
25
ď‚— Clinical presentations
ď‚— Triad:-
Goiter,thyrotoxicosis,exophthalmos
ď‚—Symptoms and signs of increased
thyroid hormone activity
ď‚—Some specific manifestations
ď‚—Graves ophtalmopaty (50%)
ď‚—Dermopathy (1-2%)
ď‚—Acropathy
ď‚—Gynecomastia in men
Toxic goiters (Grave’s) cont…
Management of goiters,sep.2010
26
ď‚— Diagnosis
ď‚—Decreased TSH
with or without
increased free
T3&T4
ď‚—Diffuse increase
in RAI uptake
ď‚—Increased
TsAb,TSH
receptor Ab
Toxic goiters (Grave’s) cont…
Management of goiters,sep.2010
27
 Treatment –focuses on hyperthyroidism,
not the autoimmunity
ď‚—Antithyroid drugs
ď‚— radioiodine ablation
ď‚—Surgery
ď‚— Choice depends on
ď‚—Age, previous therapy,cost,size of
goiter,asscociated
ophtalmopathy,availability,patients
preference etc…
Toxic goiters (Grave’s) cont…
Management of goiters,sep.2010
28
A . Antithyroid drugs
ď‚—PTU and methimazole are used
ď‚—Both act by inhibiting thyroid
peroxidase enzyme
ď‚—First line treatment in children,
adolescents
ď‚—In preparation for radiotherapy and
surgery
Toxic goiters (Grave’s) cont…
Management of goiters,sep.2010
29
ď‚—Disadvantages
ď‚—Both cross the placenta
ď‚—Side effects e.g. agranulocytosis
ď‚—Associated with high relapse rate(40-
80% in 2 years)
ď‚—Most patients improve in 2 weeks
,become euthyroid in 6 weeks
 β blockers can be used together
Toxic goiters (Grave’s) cont…
Management of goiters,sep.2010
30
B . Radioiodine therapy (I 131)
ď‚— Is the mainstay of therapy in the developed
world
ď‚— Advantages
 Avoidance of surgery and it’s risks
ď‚— Reduced cost and ease of treatment
ď‚— Disadvantages
ď‚— High chance of hypothyroidism(70% at 11
years)
ď‚— Progression of ophtalmopathy (33%)
ď‚— Fetal damage
Toxic goiters (Grave’s) cont…
Management of goiters,sep.2010
31
ď‚—Indications
ď‚—Older patients with small or moderate
sized goiters
ď‚—Relapse after medical or surgical
treatment
ď‚—Patients with contraindication for
drugs and surgery
ď‚—Contraindications
ď‚—Pregnancy and breast feeding
ď‚—Young patients
ď‚—Patients with ophtalmopathy
Toxic goiters (Grave’s) cont…
Management of goiters,sep.2010
32
C . Surgery
ď‚—Goal is complete and permanent
control
ď‚—Indications
ď‚—Young patients
ď‚—Patients with cancer or suspicious
nodule
ď‚—Allergy to antithyroid drugs
ď‚—Large goiters
ď‚—Pregnant and those with desire to
conceive soon
Toxic goiters (Grave’s) cont…
Management of goiters,sep.2010
33
ď‚— Preoperatively
ď‚—Patient should be rendered euthyroid
Lugol’s iodine (for 10 days,3 drops
BID) to decease vascularity of the
gland
ď‚— Extent of surgery
ď‚—Depend on desired outcome
(recurrence vs. euthyroidism) and
surgeons experience
Toxic goiters (Grave’s) cont…
Management of goiters,sep.2010
34
ď‚— Options
ď‚—Total or near total thyroidectomy
ď‚—Coexisting cancer
ď‚—Refusal to RAI
ď‚—Severe ophtalmopathy
ď‚—Severe reaction to drugs
ď‚—Subtotal thyroidectomy
ď‚—For all the remaining patients
Toxic goiters (Grave’s) cont…
Management of goiters,sep.2010
35
ď‚— If recurrence occurs =RAI
ď‚— Patients need long term follow up with
yearly TSH measurement
Toxic goiters cont…
Management of goiters,sep.2010
36
II.Toxic MNG
ď‚—Has slow onset and subtle symptoms,
with no extra thyroidal manifestations
ď‚—Usually in older age(>50 years) ,with
previous non toxic MNG, because of
autonomous nodules
ď‚—Diagnosis =similar to graves
ď‚—RAI-multiple nodules with increased
uptake
Scan in a patient with a toxic
multinodular goiter
Management of goiters,sep.2010
37
Toxic goiters (TMNG) cont…
Management of goiters,sep.2010
38
ď‚— Treatment
ď‚—Surgery (subtotal thyroidectomy)
ď‚—Is the preferred mode of treatment
ď‚—RAI
ď‚—Larger doses are needed
ď‚—High recurrence rate
ď‚—Only for elderly poor operative risks
ď‚—Provided no cancer or airway
compression exists
Toxic goiters (TMNG) cont…
Management of goiters,sep.2010
39
ď‚—Antithyroid drugs
ď‚—As preparation for surgery or
radiotherapy
ď‚—Not effective as long term therapy
ď‚—High recurrence rate
Toxic goiters cont…
Management of goiters,sep.2010
40
III.Toxic adenoma (Plummer's disease)
ď‚—Is hyperthyroidism from a single hyper-
functioning nodule( at least 3 cm
diameter )
ď‚—Mainly in young patients
ď‚—Thyrotoxicosis is usually mild
ď‚—Diagnosis
ď‚—Palpable nodule and symptoms of
thyrotoxicosis
ď‚—RAI = hot nodule
Iodine (I 123) scan in a patient with a
palpable nodule
Management of goiters,sep.2010
41
Toxic goiters cont…
Management of goiters,sep.2010
42
ď‚— Treatment
ď‚—Antithyroid drugs as preparation for
RAI or surgery
ď‚—RAI effective for small nodules
ď‚—Surgery( lobectomy and
isthmusectomy)
ď‚—Good for larger nodules
ď‚—PEIT (ethanol injection)
Post operative Complications
ď‚— Recurrent Laryngeal nerve injury
ď‚— Hypoparathyroidism
ď‚— Bleeding
ď‚— External Laryngeal nerve injury
ď‚— Hypothyroidism
ď‚— Recurrence
ď‚— Others
Management of goiters,sep.2010
43
References
Management of goiters,sep.2010
44
ď‚— Stephanie L Lee, e medicine, July 2006
ď‚— John L Floyd ,e medicine, march 2006
 Schwartz’s ,principles of surgery,8th ed,2005
ď‚— Laszlo Hegedus ,NEJM.2004;351;1764-1771
ď‚— Laszlo Hegedus et al,Endocrine
reviews.2003; 24(1):102-132
ď‚— Ad R.Hermus,NEJM.1998,338;1438-1447
Management of goiters,sep.2010
45
Thank you

Weitere ähnliche Inhalte

Ă„hnlich wie goitersgirmaye.ppt

management of Hyperthyroidism
management of Hyperthyroidism  management of Hyperthyroidism
management of Hyperthyroidism Zelalem Semegnew
 
2.Thyroid Gland An.ppt anatomy physiology. Pathology
2.Thyroid Gland An.ppt anatomy physiology. Pathology2.Thyroid Gland An.ppt anatomy physiology. Pathology
2.Thyroid Gland An.ppt anatomy physiology. PathologyMekdiDan
 
goiter 2-170 323180 82 2 (1).pdf
goiter         2-170 323180 82 2 (1).pdfgoiter         2-170 323180 82 2 (1).pdf
goiter 2-170 323180 82 2 (1).pdfdeborayilma
 
Hashimoto's thyroiditis 2018
Hashimoto's thyroiditis 2018Hashimoto's thyroiditis 2018
Hashimoto's thyroiditis 2018BMCStudents
 
Thyroid final
Thyroid finalThyroid final
Thyroid finalSachin Verma
 
Management of goiter
Management of goiterManagement of goiter
Management of goiterShahadad Hossain
 
Approach to a patient with Anterior Neck mass.pptx
Approach to a patient with Anterior Neck mass.pptxApproach to a patient with Anterior Neck mass.pptx
Approach to a patient with Anterior Neck mass.pptxBeerBahadurYadav1
 
EP859-PowerpointFa.pptx
EP859-PowerpointFa.pptxEP859-PowerpointFa.pptx
EP859-PowerpointFa.pptxHAMID305993
 
Thyroid disorders
Thyroid disorders Thyroid disorders
Thyroid disorders CarlaSawan2
 
Pharmacotherapy thyroid disorders
Pharmacotherapy thyroid disordersPharmacotherapy thyroid disorders
Pharmacotherapy thyroid disordersKoppala RVS Chaitanya
 
dokumen.tips_graves-disease-an-overview.ppt
dokumen.tips_graves-disease-an-overview.pptdokumen.tips_graves-disease-an-overview.ppt
dokumen.tips_graves-disease-an-overview.pptJafarMohammadi12
 
Hyperthyroidism Ppt.pptx
Hyperthyroidism Ppt.pptxHyperthyroidism Ppt.pptx
Hyperthyroidism Ppt.pptxDeepakKumarStudyID
 
2020 05-22 Options in Managing Hyperthyroidism in the Time of Covid-19
2020 05-22 Options in Managing Hyperthyroidism in the Time of Covid-192020 05-22 Options in Managing Hyperthyroidism in the Time of Covid-19
2020 05-22 Options in Managing Hyperthyroidism in the Time of Covid-19Jeremy F. Robles MD, FPCP, FPSEM
 
Presentation1.pptx, radiological imaging of the thyroid gland diseases.
Presentation1.pptx, radiological imaging of the thyroid gland diseases.Presentation1.pptx, radiological imaging of the thyroid gland diseases.
Presentation1.pptx, radiological imaging of the thyroid gland diseases.Abdellah Nazeer
 
Thyroid Disease2
Thyroid Disease2Thyroid Disease2
Thyroid Disease2Deep Deep
 
Thyroid Disorder.pptx
Thyroid Disorder.pptxThyroid Disorder.pptx
Thyroid Disorder.pptxNimonaAAyele
 

Ă„hnlich wie goitersgirmaye.ppt (20)

management of Hyperthyroidism
management of Hyperthyroidism  management of Hyperthyroidism
management of Hyperthyroidism
 
2.Thyroid Gland An.ppt anatomy physiology. Pathology
2.Thyroid Gland An.ppt anatomy physiology. Pathology2.Thyroid Gland An.ppt anatomy physiology. Pathology
2.Thyroid Gland An.ppt anatomy physiology. Pathology
 
Goiter
Goiter Goiter
Goiter
 
goiter 2-170 323180 82 2 (1).pdf
goiter         2-170 323180 82 2 (1).pdfgoiter         2-170 323180 82 2 (1).pdf
goiter 2-170 323180 82 2 (1).pdf
 
Hashimoto's thyroiditis 2018
Hashimoto's thyroiditis 2018Hashimoto's thyroiditis 2018
Hashimoto's thyroiditis 2018
 
Thyroid final
Thyroid finalThyroid final
Thyroid final
 
Hyperthyroidism
HyperthyroidismHyperthyroidism
Hyperthyroidism
 
Management of goiter
Management of goiterManagement of goiter
Management of goiter
 
Approach to a patient with Anterior Neck mass.pptx
Approach to a patient with Anterior Neck mass.pptxApproach to a patient with Anterior Neck mass.pptx
Approach to a patient with Anterior Neck mass.pptx
 
Hypothyroidism
HypothyroidismHypothyroidism
Hypothyroidism
 
EP859-PowerpointFa.pptx
EP859-PowerpointFa.pptxEP859-PowerpointFa.pptx
EP859-PowerpointFa.pptx
 
Thyroid diseases
Thyroid diseasesThyroid diseases
Thyroid diseases
 
Thyroid disorders
Thyroid disorders Thyroid disorders
Thyroid disorders
 
Pharmacotherapy thyroid disorders
Pharmacotherapy thyroid disordersPharmacotherapy thyroid disorders
Pharmacotherapy thyroid disorders
 
dokumen.tips_graves-disease-an-overview.ppt
dokumen.tips_graves-disease-an-overview.pptdokumen.tips_graves-disease-an-overview.ppt
dokumen.tips_graves-disease-an-overview.ppt
 
Hyperthyroidism Ppt.pptx
Hyperthyroidism Ppt.pptxHyperthyroidism Ppt.pptx
Hyperthyroidism Ppt.pptx
 
2020 05-22 Options in Managing Hyperthyroidism in the Time of Covid-19
2020 05-22 Options in Managing Hyperthyroidism in the Time of Covid-192020 05-22 Options in Managing Hyperthyroidism in the Time of Covid-19
2020 05-22 Options in Managing Hyperthyroidism in the Time of Covid-19
 
Presentation1.pptx, radiological imaging of the thyroid gland diseases.
Presentation1.pptx, radiological imaging of the thyroid gland diseases.Presentation1.pptx, radiological imaging of the thyroid gland diseases.
Presentation1.pptx, radiological imaging of the thyroid gland diseases.
 
Thyroid Disease2
Thyroid Disease2Thyroid Disease2
Thyroid Disease2
 
Thyroid Disorder.pptx
Thyroid Disorder.pptxThyroid Disorder.pptx
Thyroid Disorder.pptx
 

Mehr von Biniam24

Principles of pediatric Oncology GG-1.pptx
Principles of pediatric Oncology GG-1.pptxPrinciples of pediatric Oncology GG-1.pptx
Principles of pediatric Oncology GG-1.pptxBiniam24
 
5.Hypertrophic Pyloric Stenosis prp.pptx
5.Hypertrophic Pyloric Stenosis prp.pptx5.Hypertrophic Pyloric Stenosis prp.pptx
5.Hypertrophic Pyloric Stenosis prp.pptxBiniam24
 
11 Unit 5 (1).pptx zrggxxxxthtrrthrrrrrr
11 Unit 5 (1).pptx zrggxxxxthtrrthrrrrrr11 Unit 5 (1).pptx zrggxxxxthtrrthrrrrrr
11 Unit 5 (1).pptx zrggxxxxthtrrthrrrrrrBiniam24
 
2.CHD1.pptx
2.CHD1.pptx2.CHD1.pptx
2.CHD1.pptxBiniam24
 
Neuroendocrine response In trauma and sepsis.pptx
Neuroendocrine response In trauma and sepsis.pptxNeuroendocrine response In trauma and sepsis.pptx
Neuroendocrine response In trauma and sepsis.pptxBiniam24
 
Gall bladder disease.pptx
Gall bladder disease.pptxGall bladder disease.pptx
Gall bladder disease.pptxBiniam24
 
Diseases of the pleura.pptx
Diseases of the pleura.pptxDiseases of the pleura.pptx
Diseases of the pleura.pptxBiniam24
 
HEAD INJURY for lecture.ppt
HEAD INJURY for lecture.pptHEAD INJURY for lecture.ppt
HEAD INJURY for lecture.pptBiniam24
 
BLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.ppt
BLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.pptBLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.ppt
BLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.pptBiniam24
 
Meti (abdom. wall hernias).pptx
Meti (abdom. wall hernias).pptxMeti (abdom. wall hernias).pptx
Meti (abdom. wall hernias).pptxBiniam24
 
SURGICAL CONDITIONS OF THE PANCREAS.pptx
SURGICAL CONDITIONS OF THE PANCREAS.pptxSURGICAL CONDITIONS OF THE PANCREAS.pptx
SURGICAL CONDITIONS OF THE PANCREAS.pptxBiniam24
 
SURGICAL INFECTIONS (BILISSE).ppt
SURGICAL INFECTIONS (BILISSE).pptSURGICAL INFECTIONS (BILISSE).ppt
SURGICAL INFECTIONS (BILISSE).pptBiniam24
 
Chest injuries.ppt
Chest injuries.pptChest injuries.ppt
Chest injuries.pptBiniam24
 
Primairy survey.ppt
Primairy survey.pptPrimairy survey.ppt
Primairy survey.pptBiniam24
 
6.HF PPT.pptx
6.HF PPT.pptx6.HF PPT.pptx
6.HF PPT.pptxBiniam24
 
3 Rubella.ppt
3 Rubella.ppt3 Rubella.ppt
3 Rubella.pptBiniam24
 

Mehr von Biniam24 (16)

Principles of pediatric Oncology GG-1.pptx
Principles of pediatric Oncology GG-1.pptxPrinciples of pediatric Oncology GG-1.pptx
Principles of pediatric Oncology GG-1.pptx
 
5.Hypertrophic Pyloric Stenosis prp.pptx
5.Hypertrophic Pyloric Stenosis prp.pptx5.Hypertrophic Pyloric Stenosis prp.pptx
5.Hypertrophic Pyloric Stenosis prp.pptx
 
11 Unit 5 (1).pptx zrggxxxxthtrrthrrrrrr
11 Unit 5 (1).pptx zrggxxxxthtrrthrrrrrr11 Unit 5 (1).pptx zrggxxxxthtrrthrrrrrr
11 Unit 5 (1).pptx zrggxxxxthtrrthrrrrrr
 
2.CHD1.pptx
2.CHD1.pptx2.CHD1.pptx
2.CHD1.pptx
 
Neuroendocrine response In trauma and sepsis.pptx
Neuroendocrine response In trauma and sepsis.pptxNeuroendocrine response In trauma and sepsis.pptx
Neuroendocrine response In trauma and sepsis.pptx
 
Gall bladder disease.pptx
Gall bladder disease.pptxGall bladder disease.pptx
Gall bladder disease.pptx
 
Diseases of the pleura.pptx
Diseases of the pleura.pptxDiseases of the pleura.pptx
Diseases of the pleura.pptx
 
HEAD INJURY for lecture.ppt
HEAD INJURY for lecture.pptHEAD INJURY for lecture.ppt
HEAD INJURY for lecture.ppt
 
BLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.ppt
BLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.pptBLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.ppt
BLOOD TRANSFISION, INDICATIONS AND COMPLICATIONS.ppt
 
Meti (abdom. wall hernias).pptx
Meti (abdom. wall hernias).pptxMeti (abdom. wall hernias).pptx
Meti (abdom. wall hernias).pptx
 
SURGICAL CONDITIONS OF THE PANCREAS.pptx
SURGICAL CONDITIONS OF THE PANCREAS.pptxSURGICAL CONDITIONS OF THE PANCREAS.pptx
SURGICAL CONDITIONS OF THE PANCREAS.pptx
 
SURGICAL INFECTIONS (BILISSE).ppt
SURGICAL INFECTIONS (BILISSE).pptSURGICAL INFECTIONS (BILISSE).ppt
SURGICAL INFECTIONS (BILISSE).ppt
 
Chest injuries.ppt
Chest injuries.pptChest injuries.ppt
Chest injuries.ppt
 
Primairy survey.ppt
Primairy survey.pptPrimairy survey.ppt
Primairy survey.ppt
 
6.HF PPT.pptx
6.HF PPT.pptx6.HF PPT.pptx
6.HF PPT.pptx
 
3 Rubella.ppt
3 Rubella.ppt3 Rubella.ppt
3 Rubella.ppt
 

KĂĽrzlich hochgeladen

Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxMaryGraceBautista27
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfphamnguyenenglishnb
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
FILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinoFILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinojohnmickonozaleda
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptxiammrhaywood
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxAshokKarra1
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfErwinPantujan2
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 

KĂĽrzlich hochgeladen (20)

Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptx
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
FILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinoFILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipino
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptx
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 

goitersgirmaye.ppt

  • 1. Management of goiters, simple and toxic
  • 2. outline Management of goiters,sep.2010 2 ď‚— Thyroid anatomy ď‚— Thyroid physiology ď‚— Evaluation of patients with thyroid diseases ď‚— Management of simple goiters ď‚— Management of toxic goiters ď‚— References
  • 3. Thyroid anatomy Management of goiters,sep.2010 3 ď‚— two lobes connected by an isthmus ď‚— 20 grams ď‚— posterior to strap muscles in the anterior neck ď‚— lobules that contain 20 to 40 follicles each ď‚— 3 million follicles exist in the adult male
  • 5. Thyroid physiology Management of goiters,sep.2010 5 ď‚— Thyroid hormone synthesis ď‚— Iodide trapping ď‚— Oxidation of iodide & iodination of tyrosine by thyroid peroxidase ď‚— Coupling of MIT and DIT to form T4 and T3 ď‚— Hydrolysis of thyroglobulin to release free T3 and T4
  • 6. Thyroid hormone synthesis Management of goiters,sep.2010 6
  • 7. Thyroid physiology cont… Management of goiters,sep.2010 7 ď‚— All of T4 is produced in the thyroid while only 20% of T3. ď‚— T3&T4 are transported bound TBG,TBPA and TBA ď‚— Hypothalamo – pituitary – thyroid axis controls secretion
  • 8. Hypothalamo – pituitary – thyroid axis Management of goiters,sep.2010 8
  • 9. Effects of thyroid hormones Management of goiters,sep.2010 9 ď‚— Affects almost every system in the body ď‚— Fetal brain &skeletal development ď‚— Increase O2 consumption,BMR& heat production ď‚— Positive inotropic and chronotropic on heart ď‚— Increased GI motility,etc.
  • 10. Evaluation of patients with thyroid disease Management of goiters,sep.2010 10 ď‚— TFT ď‚— Serum TSH – most sensitive test for diagnosis of hypo and hyperthyroidism ď‚— Free T3&T4- for diagnosis of early hyperthyroidism ď‚— Total T3&T4-are not good for screening, can be affected by factors other than thyroid function ď‚—Calcitonin
  • 11. Evaluation cont… Management of goiters,sep.2010 11 ď‚— TRH test-to asses pituitary TSH secretion ď‚— Thyroid antibodies(anti Tg,anti TPO and TSI) ď‚— elevated in autoimmune thyroid d.(Graves d/Hashimoto’s thyroiditis) ď‚—Don’t indicate thyroid function ď‚— Serum thyroglobulin ď‚— for monitoring recurrent/metastatic thyroid ca.
  • 12. Evaluation cont… Management of goiters,sep.2010 12 ď‚— Thyroid imaging ď‚— Radionuclide imaging ď‚— Size, shape & function of gland assessed ď‚— Increased uptake=“hot", less risk of malignancy,<5% ď‚— Decreased uptake=“cold" higher risk of malignancy (15-20%) ď‚— Ultrasound ď‚— CT/ MRI good for assessment of retrosternal extension
  • 13. RAI Scanning Management of goiters,sep.2010 13
  • 14. Evaluation cont… Management of goiters,sep.2010 14 ď‚— FNAC ď‚—The best investigative modality for detecting malignancy ď‚—When guided by ultrasound has high sensitivity and specificity ď‚—Reduced thyroidectomies by 50% ď‚— Biopsy
  • 15. Simple goiters Management of goiters,sep.2010 15
  • 16. Simple goiters cont… Management of goiters,sep.2010 16 ď‚— Race = no racial predilection ď‚— Sex= female to male ratio 4:1 ď‚— Spectrum of illness ď‚—Diffuse ď‚—Uninodular(Solitary Nodule) ď‚—Multinodular ď‚—Cystic enlargement
  • 17. Diagnosis Management of goiters,sep.2010 17 ď‚— Most are asymptomatic ď‚— If symptomatic ď‚—Neck mass ď‚—Compression symptoms mainly in intrathoracic extension ď‚—Hoarseness of voice ď‚— FNAC is important to exclude malignancy
  • 18. Treatment of simple goiters Management of goiters,sep.2010 18 I. Multinodular goiters ď‚— no ideal treatment ď‚—Options are A. Iodine supplementation-not effective on nodular goiter, abandoned B.L thyroxine suppression therapy ď‚—15 – 40 % reduction in size in 3 months ď‚— More effective on small diffuse goiters
  • 19. Treatment cont… Management of goiters,sep.2010 19 C . Surgery ď‚—The preferred modality ď‚—Indicated for: -large goiters with compression symptoms, -in suspicion of malignancy & -cosmosis ď‚—Advantages ď‚— Significant goiter reduction with prompt relief of symptoms ď‚— Definitive tissue diagnosis
  • 20. Treatment cont… Management of goiters,sep.2010 20 ď‚—Disadvantages ď‚— Many complications ď‚— Recurrence in 15 – 40% ď‚— Long term risk of hypothyroidism(10-20%) D.Radioiodine therapy(I131) ď‚—Not effective in larger goiters, with higher recurrence ď‚—40- 60% reduction in size in 1 to 2 years ď‚—Small Goiters:-Recurrence is low(8%
  • 21. Management of goiters,sep.2010 21 II.Solitary nodule A.Small sized(1-1.5 cm) no treatment, followed regularly with FNAC(3-6% risk of malignancy) B.Solitary cold nodule ď‚— T4 therapy – helps to shrink the nodule ď‚— Surgery( lobectomy or isthmusectomy) ď‚— In malignant or suspicious cytology ď‚— Cosmetic ď‚— Pressure symptoms ď‚— Percutaneous ethanol injection therapy Treatment cont…
  • 22. Treatment cont… Management of goiters,sep.2010 22 III. Solitary cyst –accounts for 15-25% of thyroid nodules ď‚— FNAC needed always to exclude malignancy ď‚— If small (<2-3cm) and benign should be left untreated ď‚— If large(>2-3cm) – aspiration is effective ď‚— Surgery –in suspicious or non diagnostic cytology & recurrence after aspiration ď‚— PEIT – good success(61-95% reduction in size)
  • 23. Toxic goiters Management of goiters,sep.2010 23 ď‚— Include ď‚—Toxic diffuse goiter (Grave’s disease) ď‚—Toxic multinodular goiter (TMNG) ď‚—Toxic solitary nodule(Plummer’s disease) ď‚—Thyroiditis
  • 24. Toxic goiters cont… Management of goiters,sep.2010 24 I . Grave’s disease ď‚—Most common cause of hyperthyroidism ď‚—Prevalence of 3per 1000 in the USA ď‚—an autoimmune disease of unknown etiology ď‚—M:F ratio 1:5 and peak age of 20 - 40 years ď‚—Mediated by thyroid stimulating antibodies ď‚—The gland is diffusely & smoothly
  • 25. Toxic goiters (Grave’s) cont… Management of goiters,sep.2010 25 ď‚— Clinical presentations ď‚— Triad:- Goiter,thyrotoxicosis,exophthalmos ď‚—Symptoms and signs of increased thyroid hormone activity ď‚—Some specific manifestations ď‚—Graves ophtalmopaty (50%) ď‚—Dermopathy (1-2%) ď‚—Acropathy ď‚—Gynecomastia in men
  • 26. Toxic goiters (Grave’s) cont… Management of goiters,sep.2010 26 ď‚— Diagnosis ď‚—Decreased TSH with or without increased free T3&T4 ď‚—Diffuse increase in RAI uptake ď‚—Increased TsAb,TSH receptor Ab
  • 27. Toxic goiters (Grave’s) cont… Management of goiters,sep.2010 27 ď‚— Treatment –focuses on hyperthyroidism, not the autoimmunity ď‚—Antithyroid drugs ď‚— radioiodine ablation ď‚—Surgery ď‚— Choice depends on ď‚—Age, previous therapy,cost,size of goiter,asscociated ophtalmopathy,availability,patients preference etc…
  • 28. Toxic goiters (Grave’s) cont… Management of goiters,sep.2010 28 A . Antithyroid drugs ď‚—PTU and methimazole are used ď‚—Both act by inhibiting thyroid peroxidase enzyme ď‚—First line treatment in children, adolescents ď‚—In preparation for radiotherapy and surgery
  • 29. Toxic goiters (Grave’s) cont… Management of goiters,sep.2010 29 ď‚—Disadvantages ď‚—Both cross the placenta ď‚—Side effects e.g. agranulocytosis ď‚—Associated with high relapse rate(40- 80% in 2 years) ď‚—Most patients improve in 2 weeks ,become euthyroid in 6 weeks ď‚— β blockers can be used together
  • 30. Toxic goiters (Grave’s) cont… Management of goiters,sep.2010 30 B . Radioiodine therapy (I 131) ď‚— Is the mainstay of therapy in the developed world ď‚— Advantages ď‚— Avoidance of surgery and it’s risks ď‚— Reduced cost and ease of treatment ď‚— Disadvantages ď‚— High chance of hypothyroidism(70% at 11 years) ď‚— Progression of ophtalmopathy (33%) ď‚— Fetal damage
  • 31. Toxic goiters (Grave’s) cont… Management of goiters,sep.2010 31 ď‚—Indications ď‚—Older patients with small or moderate sized goiters ď‚—Relapse after medical or surgical treatment ď‚—Patients with contraindication for drugs and surgery ď‚—Contraindications ď‚—Pregnancy and breast feeding ď‚—Young patients ď‚—Patients with ophtalmopathy
  • 32. Toxic goiters (Grave’s) cont… Management of goiters,sep.2010 32 C . Surgery ď‚—Goal is complete and permanent control ď‚—Indications ď‚—Young patients ď‚—Patients with cancer or suspicious nodule ď‚—Allergy to antithyroid drugs ď‚—Large goiters ď‚—Pregnant and those with desire to conceive soon
  • 33. Toxic goiters (Grave’s) cont… Management of goiters,sep.2010 33 ď‚— Preoperatively ď‚—Patient should be rendered euthyroid ď‚—Lugol’s iodine (for 10 days,3 drops BID) to decease vascularity of the gland ď‚— Extent of surgery ď‚—Depend on desired outcome (recurrence vs. euthyroidism) and surgeons experience
  • 34. Toxic goiters (Grave’s) cont… Management of goiters,sep.2010 34 ď‚— Options ď‚—Total or near total thyroidectomy ď‚—Coexisting cancer ď‚—Refusal to RAI ď‚—Severe ophtalmopathy ď‚—Severe reaction to drugs ď‚—Subtotal thyroidectomy ď‚—For all the remaining patients
  • 35. Toxic goiters (Grave’s) cont… Management of goiters,sep.2010 35 ď‚— If recurrence occurs =RAI ď‚— Patients need long term follow up with yearly TSH measurement
  • 36. Toxic goiters cont… Management of goiters,sep.2010 36 II.Toxic MNG ď‚—Has slow onset and subtle symptoms, with no extra thyroidal manifestations ď‚—Usually in older age(>50 years) ,with previous non toxic MNG, because of autonomous nodules ď‚—Diagnosis =similar to graves ď‚—RAI-multiple nodules with increased uptake
  • 37. Scan in a patient with a toxic multinodular goiter Management of goiters,sep.2010 37
  • 38. Toxic goiters (TMNG) cont… Management of goiters,sep.2010 38 ď‚— Treatment ď‚—Surgery (subtotal thyroidectomy) ď‚—Is the preferred mode of treatment ď‚—RAI ď‚—Larger doses are needed ď‚—High recurrence rate ď‚—Only for elderly poor operative risks ď‚—Provided no cancer or airway compression exists
  • 39. Toxic goiters (TMNG) cont… Management of goiters,sep.2010 39 ď‚—Antithyroid drugs ď‚—As preparation for surgery or radiotherapy ď‚—Not effective as long term therapy ď‚—High recurrence rate
  • 40. Toxic goiters cont… Management of goiters,sep.2010 40 III.Toxic adenoma (Plummer's disease) ď‚—Is hyperthyroidism from a single hyper- functioning nodule( at least 3 cm diameter ) ď‚—Mainly in young patients ď‚—Thyrotoxicosis is usually mild ď‚—Diagnosis ď‚—Palpable nodule and symptoms of thyrotoxicosis ď‚—RAI = hot nodule
  • 41. Iodine (I 123) scan in a patient with a palpable nodule Management of goiters,sep.2010 41
  • 42. Toxic goiters cont… Management of goiters,sep.2010 42 ď‚— Treatment ď‚—Antithyroid drugs as preparation for RAI or surgery ď‚—RAI effective for small nodules ď‚—Surgery( lobectomy and isthmusectomy) ď‚—Good for larger nodules ď‚—PEIT (ethanol injection)
  • 43. Post operative Complications ď‚— Recurrent Laryngeal nerve injury ď‚— Hypoparathyroidism ď‚— Bleeding ď‚— External Laryngeal nerve injury ď‚— Hypothyroidism ď‚— Recurrence ď‚— Others Management of goiters,sep.2010 43
  • 44. References Management of goiters,sep.2010 44 ď‚— Stephanie L Lee, e medicine, July 2006 ď‚— John L Floyd ,e medicine, march 2006 ď‚— Schwartz’s ,principles of surgery,8th ed,2005 ď‚— Laszlo Hegedus ,NEJM.2004;351;1764-1771 ď‚— Laszlo Hegedus et al,Endocrine reviews.2003; 24(1):102-132 ď‚— Ad R.Hermus,NEJM.1998,338;1438-1447

Hinweis der Redaktion

  1. 2